Clinical Trial Update: Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment

View source ↗

Summary

This clinical trial aims to establish an ex vivo collection of triple-negative breast cancers to evaluate innovative therapies and identify predictive biomarker…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Triple Negative Breast Cancer, Organoid | Status: RECRUITING